Metabolism
Serine/threonine kinase AMPK upregulates glucose uptake by promoting the expression and function of glucose transporters. AMPK is activated by increased AMP/ATP ratio, resulting from cellular and environmental stress, e.g. low glucose, heat shock, hypoxia and ischemia. AMPK activation positively modulates signaling transductions that refill ATP levels. Moreover, it also stimulates catabolic processes such as fatty acid oxidation and glycolysis through inhibition of ACC and activation of PFK2. AMPK negatively regulates various proteins which are important to ATP-consuming mechanisms, e.g. mTORC2, glycogen synthase, SREBP-1, and TSC2, causing the downregulation/inhibition of gluconeogenesis and glycogen, lipid and protein synthesis.
- B8221 Liproxstatin-1 HClSummary: A potent ferroptosis inhibitor
- B8354 PapainSummary: A cysteine protease of the peptidase C1 family
- A8704 StiripentolTarget: Lactate Dehydrogenases (LDH)Summary: An LDH inhibitor
- A8703 IsosafroleTarget: Lactate Dehydrogenases (LDH)Summary: A stiripentol analog, a potent LDH inhibitor.
- B7862 2-DeoxycytidineSummary: A cytidine analog
- B7869 4-Aminobenzoic acidSummary: An intermediate in the synthesis of folate0
- B7888 Glyoxylic acidSummary: Both an aldehyde and a carboxylic acid
- B7904 N-acetyl D-galactosamineSummary: An endogenous metabolite
- B7911 Pyridoxal hydrochlorideSummary: An endogenous metabolite
- A4015 DisulfiramTarget: Aldehyde DehydrogenasesSummary: Dopamine β-hydroxylase inhibitor